ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 33 filers reported holding ELEDON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $303,908 | -41.9% | 221,830 | 0.0% | 0.05% | -59.7% |
| Q1 2023 | $523,518 | +1.7% | 221,830 | 0.0% | 0.12% | -4.0% |
| Q4 2022 | $514,645 | -15.9% | 221,830 | 0.0% | 0.12% | +1.6% |
| Q3 2022 | $612,000 | -30.8% | 221,830 | -38.8% | 0.12% | -24.2% |
| Q2 2022 | $884,000 | -38.1% | 362,537 | 0.0% | 0.16% | -14.4% |
| Q1 2022 | $1,429,000 | -5.9% | 362,537 | +5.2% | 0.19% | -16.8% |
| Q4 2021 | $1,519,000 | -28.7% | 344,578 | 0.0% | 0.23% | +50.7% |
| Q3 2021 | $2,129,000 | -23.1% | 344,578 | -1.5% | 0.15% | -33.0% |
| Q2 2021 | $2,769,000 | +3.5% | 350,000 | +40.0% | 0.22% | +148.9% |
| Q1 2021 | $2,676,000 | – | 250,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $8,280,000 | 0.60% |
| CM Management, LLC | 75,000 | $464,000 | 0.35% |
| BVF INC/IL | 1,363,435 | $8,426,000 | 0.33% |
| Cormorant Asset Management, LP | 1,305,095 | $8,065,000 | 0.33% |
| Ikarian Capital, LLC | 344,578 | $2,129,000 | 0.15% |
| Woodline Partners LP | 781,376 | $4,829,000 | 0.08% |
| Eversept Partners, LP | 114,008 | $704,569 | 0.05% |
| INGALLS & SNYDER LLC | 51,149 | $316,000 | 0.01% |
| Virtu Financial LLC | 18,610 | $115,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 34,630 | $214,000 | 0.01% |